Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BK).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - EU Market Recap: FTSE 100 +0.56% to 8680.29, DAX +0.73% to 23154.57, CAC40 +0.57% to 8073.98, STOXX 600 +0.79% to 550.94

Mar 17 ,2025

  • Synopsis:

    • European indices ended higher Monday. Follows last week's downbeat performance, although markets closed higher on Friday. Among EU sectors, Energy and Health Care the best performers. Chemicals and Personal & Household Goods main laggards.

    • Markets supported by Friday's news of German lawmakers close to agreeing on reforming debt brake rule. Bundestag expected to vote on the constitutional change on Thursday. Press said CDU leader Merz won support from Greens to allow increase in defense spending.

    • No major macro data in Europe. UK think tank Resolution Foundation said slowdown in hiring suggests economy heading for recession. UK manufacturing industry group Make UK said UK output fell in Q1 Chancellor Reeves continues to focus on boosting growth measures ahead of next week's fiscal statement. Government to outlook changes to welfare benefits on Tuesday to save £6B a year.

    • In M&A news, General Atlantic is nearing deal to take up-to-10% stake in ProSiebenSat.1 Media (PSM.GR); still in Germany, following some speculation, Porsche Automobil Holding (PAH3.GR) has denied selling any Volkswagen (VOW3.GR) shares. In France, Bpifrance, the public investment bank, and its French sovereign wealth fund Lac1 announced that they are acquiring a €800M stake in Veolia (VIE.FP) and Bureau Veritas (BVI.FP) acquired GeoAssay in Chile; other deals include, AstraZeneca (AZN.LN) acquired Belgium's EsoBiotec for up to $1B, talks to combine ITV (ITV.LN) and All3Media (A3M.SM) are progressing and Blackstone made a non-binding $1.2B offer for Akzo Nobel India's (AKZA.NA) paints business.

    • Elsewhere, LVMH (MC.FP)'s Loewe creative director Jonathan Anderson has reportedly stepped down and - in the UK - shares in Tesco (TSCO.LN) and Sainsbury (SBRY.LN) are continuing to slide after Asda announced 5-10% price investments on Friday.

    • Looking ahead to tomorrow's EU econ-calendar, notable releases will include, amongst others, Germany ZEW survey, Italy Jan trade balance and Eurozone Jan trade balance.

  • Digest:

    • Sectors - STOXX Europe 600:

      • Outperformers:

        • Oil & Gas +1.58%, Health Care +1.36%, Travel & Leisure +0.98%, Food & Beverage +0.96%, Insurance +0.95%, Real Estate +0.91%, Basic Resources +0.91%, Banks +0.85%, Utilities +0.78%

      • Underperformers:

        • Chemicals +0.03%, Persnl & HHold Goods +0.05%, Construct & Mtls +0.21%, Telecom +0.47%, Retail +0.70%, Autos & Parts +0.59%, Ind Goods & Svcs +0.57%, Financial Svcs +0.70%, Technology +0.76%, Utilities +0.75%

    • Macro:

      • Central banks:

        • ECB's Guindos Sees Services Inflation Moving Toward Lower Levels -- Bloomberg

      • UK:

        • UK's Reeves says financial regulators responding to her cull of red tape -- Reuters

        • Work and pensions secretary confirms welfare reforms are coming 'imminently' -- Skynews

      • Germany:

        • Merz's borrowing plans face last-ditch challenge in German court -- Reuters

    • Company news:

      • Notable Gainers

        • +28.6% BGBIO.NO (BerGenBio NOK1.94, +0.43) -- strategic review update

        • +10.7% PHNX.LN (Phoenix Group Holdings £5.76, +0.56) -- FY earnings

        • +10.6% VCP.LN (Victoria £0.96, +0.09) -- new CFO

        • +9.0% VIRP.FP (Virbac €322.00, +26.50) -- Stifel upgrade

        • +8.6% CVSG.LN (CVS Group £10.64, +0.84) -- RBC Capital Markets upgrade

        • +8.5% PSM.GR (ProSiebenSat.1 Media €6.80, +0.54) -- General Atlantic near deal to take up-to-10% stake in ProSiebenSat.1 Media - Bloomberg

        • +8.5% DEC.LN (Diversified Energy Co. £9.96, +0.78) -- FY earnings

        • +8.0% XXL.NO (XXL ASA NOK10.95, +0.81) -- oversubsrcibed right issue

        • +7.6% SESG.FP (SES €5.90, +0.42) -- sharheolder Appaloosa statement

        • +6.8% UBXN.SW (u-blox Holding CHF85.00, +5.40) -- divests its Cellular business to Trasna

        • +5.0% NRC.NO (NRC Group NOK5.48, +0.26) -- contract

        • +5.0% BAHN.B.SS (Bahnhof SEK51.70, +2.45) -- initiated buy at Pareto

        • +4.8% BNOR.NO (BlueNord NOK649.00, +30.00) -- annual Statement of Reserve

        • +4.6% IDIA.SW (Idorsia CHF1.18, +0.05) -- TRYVIO released from FDA's REMS

        • +4.4% EYE.LN (Eagle Eye Solutions Group £3.76, +0.16) -- H1 earnings

        • +4.3% NDX1.GR (Nordex €16.91, +0.70) -- 94 MW order

        • +2.7% BVC.LN (BATM Advanced Communications £0.15, -0.00) -- FY earnings

        • +2.5% ALHGR.FP (Hoffmann Green Cement Technologies €4.99, +0.12) -- FY earnings

        • +2.1% PRS.SM (Promotora de Informaciones €0.40, +0.01) -- Spain pressure Vivendi to sell its stake in Prisa -- Le Point

        • +2.0% VIE.FP (Veolia Environnement €31.20, +0.60) -- Bpifrance to acquire €800M stake

        • +1.4% KOG.NO (Kongsberg Gruppen NOK1,674.00, +23.00) -- starts operating its first satellite

        • +1.3% FORT.LN (Forterra Plc £1.62, +0.02) -- Peel Hunt upgrade

        • +1.0% ALBPS.FP (Biophytis €0.33, -0.00) -- SARA-INT Phase II results publication

        • +0.4% LEG.GR (LEG Immobilien €67.90, +0.28) -- Deutsche Bank downgrade

      • Notable Decliners

        • -20.6% QQ.LN (QinetiQ Group £4.17, -1.08) -- Q4 trading Update

        • -8.0% ENOG.LN (Energean £8.70, -0.75) -- risk of termination for sale of assets in Egypt, Italy & Croatia to Carlyle

        • -4.4% TSCO.LN (Tesco plc £3.23, -0.15) -- Asda price investments reaction

        • -4.0% ASC.LN (Asos £2.39, -0.10) -- BNP Paribas Exane downgrade

        • -3.1% IVSO.SS (INVISIO SEK431.50, -14.00) -- Carnegie Securities downgrade

        • -2.7% MSLH.LN (Marshalls £2.35, -0.06) -- FY earnings

        • -2.2% ASSA.B.SS (Assa Abloy SEK309.60, -7.10) -- acquires Gesellschaft für Sicherheitstechnik; DnB Markets downgrade

        • -1.2% ZEAL.DC (Zealand Pharma DKK578.50, -7.00) -- completes enrollment for Phase 2B ZUPREME-1 trial of petrelintide in people with overweight or obesity

        • -1.1% SBRY.LN (J Sainsbury £2.32, -0.03) -- Asda price investments reaction

        • -0.4% WAF.GR (Siltronic €46.74, -0.20) -- Jefferies downgrade

    • EU companies reporting tomorrow:

      • Earnings:

        • Benelux: B&S Group (BSGR.NA)

        • DACHs: Fraport AG Frankfurt Airport Services Worldwide (FRA.GR), Springer Nature (SPG.GR), Medartis Holding (MED.SW), Mayr-Melnhof Karton (MMK.AV)

        • France: Assystem (ASY.FP), Deezer (DEEZR.FP)

        • Southern Europe: Brembo (BRE.IM), Aquafil (ECNL.IM)

        • UK: National Atomic Company Kazatomprom (KAP.LN), Close Brothers Group (CBG.LN), Midwich Group (MIDW.LN), Trustpilot Group (TRST.LN), Mortgage Advice Bureau (MAB1.LN), Sabre Insurance Group (SBRE.LN), Genel Energy (GENL.LN), H&T Group (HAT.LN), RM (RM.LN), The Pebble Group (PEBB.LN), Renalytix (RENX.LN), Fintel (FNTL.LN), Atalaya Mining (ATYM.LN)

  • Data:

    • Economics:

      • Italy Feb CPI +1.6% y/y vs preliminary +1.7%

      • Norway Feb trade balance NOK84.7B vs consensus NOK74.6B, prior NOK94.8B

    • Markets:

      • WTI Crude (25-Apr): +$0.41 or +0.61% to $67.59

      • €-$ +0.0040 or +0.36% to 1.0922

      • £-$ +0.0057 or +0.44% to 1.2988

      • €-£ (0.0007) to 0.8409

      • S&P 500 +0.25%

      • Performance year-to-date:

        • FTSE 100: +6.21%

        • DAX: +16.30%

        • CAC: +9.39%

        • MIB: +14.15%

        • Stoxx 600: +8.53%

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE